Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov;28(11):3870-3872.
doi: 10.1111/ene.14966.

A fatal case of COVID-19-associated acute necrotizing encephalopathy

Dace Ziemele  1   2 , Gundega Ķauķe  1   2 , Krista Skrējāne  2 , Līga Jaunozoliņa  2   3 , Guntis Karelis  1   2
Affiliations
Case Reports

A fatal case of COVID-19-associated acute necrotizing encephalopathy

Dace Ziemele et al. Eur J Neurol. 2021 Nov.

Abstract

Introduction: An increasing number of published reports on SARS-CoV-2 neurological manifestations have revealed a wide spectrum of symptoms, diagnostic features, and outcomes. We report a fatal case of a COVID-19-associated acute necrotizing encephalopathy (ANE).

Case report: We report a 70-year-old man brought to the hospital after a generalized tonic-clonic seizure. He was confused and disoriented. Nasopharyngeal swab testing for SARS-CoV-2 was positive. A head computed tomography (CT) scan and cerebrospinal fluid (CSF) analysis showed no signs of acute pathology. After recurrent seizures, he was sedated and intubated. Throughout the days that followed he remained in a therapeutic coma. After discontinuation of sedatives, he remained unconscious. A repeated head CT scan showed signs of pontine edema, and brain magnetic resonance imaging (MRI) revealed inhomogeneous hyperintensities with microhemorrhages and small autonecrotic cavities in both thalami, brain stem, and cerebellar peduncles. With a high suspicion of a COVID-19-associated ANE, the patient was started on high-dose glucocorticoids; however, he died the next day. The CSF tested negative for SARS-CoV-2.

Discussion: A variety of COVID-19 neurological manifestations have been reported to date, including various forms of encephalitis and encephalopathy. In our patient, encephalopathy with seizures was the presenting symptom of SARS-CoV-2 infection. The radiological findings on days 8 and 9 were consistent with an ANE. The precise pathogenesis of ANE remains unclear; however, an immune-mediated mechanism is suspected. Early diagnostics with prompt administration of immunomodulators may be lifesaving. Suspicion of a COVID-19-related encephalopathy/encephalitis should be raised in all patients with altered mental status, seizures, and/or coma.

Keywords: COVID-19; SARS-CoV-2; necrotizing encephalopathy; neurological manifestations.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
CT and MRI findings in a 70‐year‐old man with COVID‐19 associated acute necrotizing encephalopathy
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Paterson RW, Brown RL, Benjamin L, et al. The emerging spectrum of COVID‐19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104‐3120. - PMC - PubMed
    1. Pilotto A, Masciocchi S, Volonghi I, et al. Clinical presentation and outcomes of severe acute respiratory syndrome coronavirus 2‐related encephalitis: the ENCOVID multicenter study. J Infect Dis. 2021;223(1):28‐37. - PMC - PubMed
    1. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID‐19‐associated acute hemorrhagic necrotizing encephalopathy: Imaging features. Radiology. 2020;296(2):E119‐E120. - PMC - PubMed
    1. Dixon L, Varley J, Gontsarova A, et al. COVID‐19‐related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflammation. 2020;7(5):1‐8. - PMC - PubMed
    1. Cao A, Rohaut B, Le Guennec L, et al. Severe COVID‐19‐related encephalitis can respond to immunotherapy. Brain. 2020;143(12):e102. - PMC - PubMed

Publication types